TCF National Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

TCF National Bank’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$2.13M	Sell	9,904 -411	-4%	-$90.3K	0.24%	107
2020 Q4	$2.44M	Buy	10,315 +289	+3%	+$66.3K	0.26%	96
2020 Q3	$2.73M	Sell	10,026 -2,237	-18%	-$617K	0.32%	76
2020 Q2	$2.25M	Buy	12,263 +3,727	+44%	+$1.01M	0.26%	96
2020 Q1	$2.03M	Sell	8,536 -298	-3%	-$68.4K	0.3%	82
2019 Q4	$1.93M	Buy	8,834 +990	+13%	+$200K	0.22%	109
2019 Q3	$1.33M	Buy	+7,844	New	+$1.39M	0.16%	147

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

TCF National Bank's VRTX Position: Q1 2021 in Review

TCF National Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 4% in Q1 2021, selling an estimated $90.3K and leaving 9,904 shares worth $2.13M. The position accounts for 0.24% of the portfolio, ranked #107.

TCF National Bank first reported a position in VRTX in Q3 2019 and has held it in 7 quarters since. The position peaked at $2.73M in Q3 2020. 999 funds tracked by Wall St. Rank hold VRTX as of Q1 2021.

TCF National Bank held 9,904 shares of Vertex Pharmaceuticals worth $2.13M as of Q1 2021.
TCF National Bank sold 411 Vertex Pharmaceuticals shares in Q1 2021, an estimated $90.3K.
Vertex Pharmaceuticals made up 0.24% of TCF National Bank's portfolio in Q1 2021, its #107 holding.
TCF National Bank first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 7 quarters since.
TCF National Bank's Vertex Pharmaceuticals position peaked at $2.73M in Q3 2020.
999 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2021.

Based on TCF National Bank's 13F filing for Q1 2021, filed 30 Apr 2021.